UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice

Frontiers in pharmacology, 2020-01, Vol.10, p.1609-1609

2020

Volltextzugriff (PDF)

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

Critical care (London, England), 2023-06, Vol.27 (1), p.226-226, Article 226

2023

Volltextzugriff (PDF)

Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study

BMC psychiatry, 2024-05, Vol.24 (1), p.394-394, Article 394

2024

Volltextzugriff (PDF)

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

Trials, 2022-02, Vol.23 (1), p.158-17, Article 158

2022

Volltextzugriff (PDF)

Current and remitted depression and anxiety disorders as risk factors for medication nonadherence

The journal of clinical psychiatry, 2015-09, Vol.76 (9), p.e1114

2015

Volltextzugriff (PDF)

Three Prospective Case Studies Examining Mifepristone’s Efficacy in Patients with Treatment-Resistant PTSD

Case reports in psychiatry, 2024, Vol.2024, p.1-6

2024

Volltextzugriff (PDF)

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study

CPT: pharmacometrics and systems pharmacology, 2021-12, Vol.10 (12), p.1497-1511

2021

Volltextzugriff (PDF)

Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression

Clinical pharmacology and therapeutics, 2024-05, Vol.115 (5), p.971-987

2024

Volltextzugriff (PDF)

Side effects of antidepressants during long-term use in a naturalistic setting

European neuropsychopharmacology, 2013-11, Vol.23 (11), p.1443-1451

2013

Volltextzugriff (PDF)

Vitamin D supplementation for the prevention of depression and poor physical function in older persons: the D-Vitaal study, a randomized clinical trial

The American journal of clinical nutrition, 2019-11, Vol.110 (5), p.1119-1130

2019

Volltextzugriff (PDF)

Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP)

Frontiers in psychiatry, 2018-04, Vol.9, p.118-118

2018

Volltextzugriff (PDF)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids

Human reproduction (Oxford), 2022-05, Vol.37 (5), p.884-894

2022

Volltextzugriff (PDF)

Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial

The American journal of clinical nutrition, 2022-08, Vol.116 (2), p.491-499

2022

Volltextzugriff (PDF)

Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists

British journal of clinical pharmacology, 2024-02, Vol.90 (2), p.392-405

2024

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

European journal of pharmaceutical sciences, 2023-05, Vol.184, p.106418-106418, Article 106418

2023

Volltextzugriff (PDF)

Risk–efficacy balance of ulipristal acetate compared to surgical alternatives

British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2685-2697

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Psychotropics as a Diagnostic Tool for CYP2D6 Poor Metabolizer Phenotype

Therapeutic drug monitoring, 2021-10, Vol.43 (5), p.672

2021

Volltextzugriff (PDF)

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2021-05, Vol.73 (5), p.806-815

2021

Volltextzugriff (PDF)

Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial

Age and ageing, 2018-01, Vol.47 (1), p.48-55

2018

Volltextzugriff (PDF)

Short-Term Effects of Methylphenidate on Math Productivity in Children With Attention-Deficit/Hyperactivity Disorder are Mediated by Symptom Improvements: Evidence From a Placebo-Controlled Trial

Journal of clinical psychopharmacology, 2017-04, Vol.37 (2), p.210-219

2017

Volltextzugriff (PDF)

Enteral Glutamine Administration in Critically Ill Nonseptic Patients Does Not Trigger Arginine Synthesis

Journal of Nutrition and Metabolism, 2016-01, Vol.2016, p.1373060-13

2016

Volltextzugriff (PDF)

Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion

American journal of health-system pharmacy, 2021-10, Vol.78 (21), p.1944-1951

2021

Volltextzugriff (PDF)

Implementation of a pharmacist‐led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH)

Journal of clinical pharmacy and therapeutics, 2022-07, Vol.47 (7), p.1049-1069

2022

Volltextzugriff (PDF)

Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?

European journal of pediatrics, 2020-08, Vol.179 (8), p.1205-1211

2020

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(52)
Berichte
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

Current and remitted depression and anxiety disorders as risk factors for medication nonadherence

Three Prospective Case Studies Examining Mifepristone’s Efficacy in Patients with Treatment-Resistant PTSD

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression

Side effects of antidepressants during long-term use in a naturalistic setting

Vitamin D supplementation for the prevention of depression and poor physical function in older persons: the D-Vitaal study, a randomized clinical trial

Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids

Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial

Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

Risk–efficacy balance of ulipristal acetate compared to surgical alternatives

Therapeutic Drug Monitoring of Psychotropics as a Diagnostic Tool for CYP2D6 Poor Metabolizer Phenotype

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six‐Month Results of a Placebo‐Controlled Trial

Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial

Short-Term Effects of Methylphenidate on Math Productivity in Children With Attention-Deficit/Hyperactivity Disorder are Mediated by Symptom Improvements: Evidence From a Placebo-Controlled Trial

Enteral Glutamine Administration in Critically Ill Nonseptic Patients Does Not Trigger Arginine Synthesis

Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion

Implementation of a pharmacist‐led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH)

Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?

Suchergebnisse filtern